SCHEMBL16634465

SCHEMBL16634465

Nc1ccc(S(=O)(=O)Nc2nc3ccccc3s2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.70
▸ GAA P10253 1/20 0.64
▸ STAT3 P40763 1/20 0.62
▸ MAPT P10636 1/20 0.60
▸ MEN1 O00255 6/20 0.59
▸ KMT2A Q03164 6/20 0.59
▸ LMNA P02545 3/20 0.58
▸ HTT P42858 2/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ CRHBP P24387 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58
▸ KDM4E B2RXH2 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ ALOX12 P18054 2/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ CYP2C9 P11712 1/20 0.53
▸ POLB P06746 1/20 0.52
▸ CASP6 P55212 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL617744 0.88 ALDH1A1 (0.72) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL19771115 0.86 ALDH1A1 (0.74) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL16554007 0.82 ALDH1A1 (0.65) ALDH1A1STAT3MEN1KMT2ALMNA
SCHEMBL16634461 0.82 PTPN1 (0.70) ALDH1A1STAT3MAPTMEN1KMT2A
SCHEMBL13265917 0.79 MEN1 (0.55) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL26961072 0.79 GAA (0.81) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL11219126 0.79 IDO1 (0.61) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL30873118 0.77 MEN1 (0.58) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL27183381 0.77 MEN1 (0.58) ALDH1A1GAASTAT3MAPTMEN1
SCHEMBL4866067 0.75 NPC1 (0.65) ALDH1A1GAASTAT3MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054936-B1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EASTERN VIRGINIA MEDICAL SCHOOL (US) 2023-10-18 — — EP disclosed
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2022-03-15 — — US disclosed
US-20200392077-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-12-17 — — US disclosed
US-10752581-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2020-08-25 — — US disclosed
US-20190276395-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-09-12 — — US disclosed
US-10266488-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2019-04-23 — — US disclosed
US-20170001955-A1 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase THOMAS JEFFERSON UNIVERSITY 2017-01-05 — — US disclosed
EP-3054936-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS Eastern Virginia Medical School (US) 2016-08-17 — — EP disclosed
WO-2015054662-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EASTERN VIRGINIA MEDICAL SCHOOL (US) 2015-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266488-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885
US-20200392077-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885
US-20190276395-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885
US-10752581-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885
US-20170001955-A1 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase ALOX12, ALOX15, ALOX15B ALDH1A1 3051/4885GAA 3560/4885STAT3 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback